Vitamin D Supplementation in Patients with Chronic Kidney Disease

Joint Bone Spine

Volumn 79, Issue SUPPL. 2, 2012, Pages

  Cheriet, Sarah ^a   Royer, Matthieu ^b   Rajzbaum, Gérald ^c   Tremollières, Florence ^d  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d Paul Sabatier University   (France)

Author keywords

Renal failure; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIFEDIOL; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PHOSPHORUS; PLACEBO; SERUM ALBUMIN;

ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DIALYSIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; META ANALYSIS (TOPIC); PARATHYROID HORMONE BLOOD LEVEL; PATIENT IDENTIFICATION; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84867929262     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/S1297-319X(12)70018-0     Document Type: Article

References (17)

1. Urena-Torres P., Metzger M., Haymann J.P., et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone metabolism. Am J Kidney Dis 2011, 58:544-553.
2. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardio-vascular disease?. J Am Col J Cardiol 2002, 39:695-701.
3. Am J Kidney Dis 2003, 42:S1-S201. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease.
4. Kidney Int 2009, 79:S1-S130. KDIGO Guideline for Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD).
5. Pilz S., Iodice S., Zittermann A., et al. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011, 58:374-382.
6. Kandula P., Dobre M., Schold J.D., et al. Vitamin D supplementation in chronic kidney disease: A systematic review and metaanalysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011, 6:50-62.
7. Chandra P., Binongo J.N., Ziegler T.R., et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008, 14:10-17.
8. Tokmak F., Quack I., Schieren G., et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008, 23:4016-4020.
9. Jean G., Souberbielle J.C., Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009, 24:3799-3805.
10. Matias P.J., Jorge C., Ferreira C., et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimensions parameters. Clin J Am Soc Nephrol 2010, 5:905-911.
11. Courbebaisse M., Thervet E., Souberbielle J.C. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney International 2009, 75:646-651.
12. nd National ODISSEE Meetings (Osteoporosis: DIagnosis and Surveillance of SEvErity). Joint Bone Spine 2011, 79(Suppl 2):S191-S196.
13. Roux C. First National ODISSEE Meetings (Osteoporosis: DIagnosis and Surveillance of SEvErity) Managing Severe Osteoporosis: from Diagnosis to Treatment. Joint Bone Spine 2010, 77(Suppl 2):S101-S102.
14. Benhamou CL, Souberbielle JC, Cortet B, et al. La vitamine D chez l'adulte. Recommandations du GRIO. Press Med 2012 (in press).[In French].
15. Briot K., Cortet B., Thomas T., et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 2012, 79:304-313.
16. Heaney R.P., Recker R.R., Grote J., et al. Vitamin D(3) is more potent in humans than vitamin D(2). J Clin Endocrinol Metab 2011, 96:E447-E452.
17. Rousière M. The calcium controversy. Joint Bone Spine 2010, 77:499-500.